Rani Therapeutics Holdings, Inc.RANINASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P20
Within normal range
vs 3Y Ago
-0.3x
Contraction
Streak
3 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | -32.66% |
| 2023 | 8.24% |
| 2022 | 38.23% |
| 2021 | 119.88% |
| 2020 | -51.00% |
| 2019 | 0.00% |